Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkinsonism
FUSAP
1 other identifier
observational
8
1 country
1
Brief Summary
The goal of this retrospective observational study is to describe the efficacy of focused ultrasound ventral-intermediate nucleus thalamotomy in patients with atypical parkinsonism.
- Is this treatment efficacious in patients with multiple system atrophy?
- Is this treatment efficacious in patients with diffuse Lewy Body Dementia? Data will be collected from patients charts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedFirst Submitted
Initial submission to the registry
December 31, 2023
CompletedFirst Posted
Study publicly available on registry
January 12, 2024
CompletedJanuary 12, 2024
January 1, 2024
9.6 years
December 31, 2023
January 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical Rating Scale for Tremor
tremor assessment by Clinical Rating Scale for Tremor. Scores ranging from 0 to 156, with higher scores indicating more severe tremor.
baseline, pre-procedure, 1 month, 6 months and 1 year following procedure
Interventions
Data collection
Eligibility Criteria
Patients that underwent FUS VIM-thalamotomy and suffered from MSA or DLBD
You may not qualify if:
- Patients that did not underwent FUS ventral-intermediate nucleus thalamotomy
- Patients that underwent FUS ventral-intermediate nucleus thalamotomy and do not suffer from MSA or DLBD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam Health Care Campus
Haifa, 3109601, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Movement Disorders Institute, clinical senior lecturer, Chair of Neurology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology Haifa, Israel
Study Record Dates
First Submitted
December 31, 2023
First Posted
January 12, 2024
Study Start
November 1, 2013
Primary Completion
May 31, 2023
Study Completion
May 31, 2023
Last Updated
January 12, 2024
Record last verified: 2024-01